Consensus Healthpeak Properties, Inc.

Equities

DOC

US42250P1030

Market Closed - Nyse Other stock markets 04:00:02 2024-04-22 pm EDT			5-day change	1st Jan Change
18.23 ^USD	+1.39%		-0.33%	-7.93%

Apr. 12	Hashicorp Insider Sold Shares Worth $366,031, According to a Recent SEC Filing	MT
Apr. 10	RBC Ups Price Target on Healthpeak Properties to $22 From $21, Keeps Outperform Rating	MT

Evolution of the average Target Price on Healthpeak Properties, Inc.

Price target over the last 5 years

History of analyst recommendation changes

be9cdb31b325bae8fd1e.U-jjr4IzwUP912vmxKhZovhUmEloBfPCcyJ0MutvlEw.IaqmlvVahzCthA6kp-og2M4A-SMARoesERIad6ol03swjdP58WuFE5utLg~574b2ef6101c65455e79fba717936a73

Analyst Recommendations on Healthpeak Properties, Inc.

Hashicorp Insider Sold Shares Worth $366,031, According to a Recent SEC Filing	Apr. 12	MT
RBC Ups Price Target on Healthpeak Properties to $22 From $21, Keeps Outperform Rating	Apr. 10	MT
Hashicorp Insider Sold Shares Worth $922,392, According to a Recent SEC Filing	Apr. 04	MT
BofA Securities Upgrades Healthpeak Properties to Buy From Underperform, Adjusts Price Target to $25 From $18	Apr. 01	MT
Hashicorp Insider Sold Shares Worth $250,742, According to a Recent SEC Filing	Mar. 22	MT
ANALYST RECOMMENDATIONS : Coinbase, Dell Technologies, Mongodb, Broadcom, Lucid Group...	Mar. 08
ANALYST RECOMMENDATIONS : Doordash, Merck, Eli Lilly, Walt Disney, Pearson...	Mar. 04
Morocco's unemployment rate at 13% in 2023- statistics agency	Feb. 05	RE
Deutsche Bank Initiates Healthpeak Properties With Hold Rating, $21 Price Target	Jan. 30	MT
Scotiabank Upgrades Healthpeak Properties to Sector Outperform From Sector Perform, Price Target is $23	Jan. 12	MT
KeyBanc Downgrades Physicians Realty Trust to Sector Weight From Overweight, Removes $17 Price Target Amid Healthpeak Properties Deal	Jan. 05	MT
BNP Paribas Starts Healthpeak Properties at Underperform Rating, $18 Price Target	23-10-11	MT
Here we go again	23-10-06
ANALYST RECOMMENDATIONS : Autozone, Burberry, Sherwin-Williams, Tullow Oil, Wizz Air...	23-10-06
Scotiabank Cuts Healthpeak Properties Price Target to $20 From $22, Maintains Sector Perform Rating	23-10-05	MT
Wedbush Starts Healthpeak Properties at Neutral With $19 Price Target	23-10-03	MT
Morgan Stanley Adjusts Price Target on Healthpeak Properties to $22 From $25, Maintains Equal-Weight Rating	23-09-07	MT
Barclays Adjusts Price Target on Healthpeak Properties to $32 From $33, Maintains Overweight Rating	23-07-25	MT
RBC Cuts Price Target on Healthpeak Properties to $25 From $28, Maintains Sector Perform Rating	23-05-04	MT
Morocco's Q1 unemployment rate up slightly at 12.9%	23-05-03	RE
Mizuho Upgrades Healthpeak Properties to Buy From Neutral, Adjusts Price Target to $25 From $29	23-04-24	MT
Fitch Affirms and Withdraws Healthpeak's Ratings	23-04-12	AQ
Citigroup Downgrades Healthpeak Properties to Neutral From Buy, Price Target is $23	23-04-06	MT
Scotiabank Downgrades Healthpeak Properties to Sector Perform From Sector Outperform, Lowers Price Target to $24 From $27	23-03-31	MT
Morgan Stanley Adjusts Price Target on Healthpeak Properties to $25 From $23, Maintains Equalweight Rating	23-03-10	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

18.23 USD

Average target price

21.66 USD

Spread / Average Target

+18.79%

High Price Target

30.5 USD

Spread / Highest target

+67.31%

Low Price Target

18 USD

Spread / Lowest Target

-1.26%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Healthpeak Properties, Inc.

RBC Capital Markets
BofA Securities
Deutsche Bank Securities
Scotiabank
BNP Paribas Exane
Wedbush
Morgan Stanley
Barclays
Mizuho Securities
Citigroup
Jefferies & Co.
Evercore ISI
Wolfe Research
Berenberg Bank
BMO Capital
Credit Suisse
JPMorgan Chase
Wells Fargo Securities
Argus
J.P. Morgan Chase

Ratings for Healthpeak Properties, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar